Upstream Bio, Inc. (UPB) stock
UPBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.78−0.08 (-2.80%)
Close on Nov 13, 2026Market cap $152.26MP/E –Yield –
Upstream Bio enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Upstream Bio's enterprise value was -$86.04M on Nov 11, 2026, against $1.17B a year earlier. Over the last 2 years it ranged from -$188.07M to $1.31B, with a median of $82.01M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$86.04M | -107.9% |
| 2025 | Dec 31, 2025 | $1.09B | – |
| 2024 | Dec 31, 2024 | -$170.92M | – |
See a number that looks wrong?